Celestial Biolabs Limited reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2016. For the quarter, the company reported sales of INR 76.683 million against INR 70.082 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 8.664 million against INR 9.490 million a year ago. Profit from ordinary activities before tax was INR 8.664 million against INR 6.246 million a year ago. Net profit for the period was INR 7.013 million against INR 5.090 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 0.31 against INR 0.27 a year ago. For the nine months, the company reported sales of INR 256.959 million against INR 235.257 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 21.898 million against INR 29.224 million a year ago. Profit from ordinary activities before tax was INR 21.897 million against INR 16.339 million a year ago. Net profit for the period was INR 17.725 million against INR 13.315 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 0.78 against INR 0.72 a year ago.